What is the role of steroids, such as prednisone, in the treatment of community-acquired pneumonia (CAP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Steroids in Community-Acquired Pneumonia

Steroids should not be routinely used in community-acquired pneumonia (CAP) but may benefit specific patient subgroups with severe CAP, particularly those with septic shock refractory to fluid resuscitation and with elevated CRP >150 mg/L. 1, 2

General Recommendation

The 2019 IDSA/ATS guidelines provide a strong conditional recommendation against the routine use of adjunctive steroids in patients treated for CAP 1. This position is supported by multiple studies showing:

  • No significant mortality reduction in general CAP populations 1, 3, 4
  • Potential for adverse effects including hyperglycemia (RR 1.49; 95% CI 1.01−2.19) 2
  • Increased risk of late failure (>72h after admission) with prednisolone (19.2% vs 6.4%, P = 0.04) 3

Specific Scenarios Where Steroids May Be Beneficial

Severe CAP with Septic Shock

  • Consider steroids in severe CAP with septic shock refractory to fluid resuscitation and vasopressor use 1
  • Particularly beneficial when CRP >150 mg/L 1
  • Meta-analyses have shown significant mortality reduction in severe CAP subgroups (OR = 0.26,95% CI: 0.11–0.64) 1, 5
  • Recent data suggests patients with high CRP (>204 mg/L) may derive greater mortality benefit (OR 0.43 [95% CI 0.25-0.76]) 6

Potential Benefits in Appropriate Patients

  • Reduced time to clinical stability 1, 7
  • Shortened hospital length of stay by approximately 1-3 days 1, 2, 7
  • Decreased risk of ARDS (RR 0.21,95% CI 0.08-0.59) 2
  • Reduced need for mechanical ventilation (RR 0.45,95% CI 0.26-0.79) 2

Contraindications and Cautions

  • Avoid in viral pneumonia, especially influenza, as meta-analyses show increased mortality 1, 2
  • Not recommended for non-severe CAP not requiring oxygen supplementation 2
  • Increased risk of hyperglycemia (OR 2.50 [95% CI 1.63-3.83]) 6
  • Increased risk of hospital readmission (OR 1.95 [1.24-3.07]) 6

Recommended Regimens When Indicated

For severe CAP with septic shock and elevated CRP:

  • Methylprednisolone 0.5 mg/kg IV every 12 hours for 5 days 1, 2
  • OR Prednisone 50 mg daily for 5 days (for patients who can take oral medication) 1
  • OR Hydrocortisone <400 mg/day IV for 5-7 days 2

Monitoring During Steroid Treatment

  • Close glucose monitoring, especially in first 36 hours after initiation 2
  • Implement infection surveillance as steroids blunt febrile response 2
  • Evaluate response at 72 hours 2
  • Consider GI prophylaxis with proton pump inhibitors 2

Algorithm for Decision-Making

  1. Assess CAP severity using validated tools (PSI or CURB-65)
  2. Check if patient has:
    • Severe CAP requiring ICU admission
    • Septic shock refractory to fluid resuscitation and vasopressors
    • CRP >150 mg/L
  3. Rule out viral pneumonia, especially influenza
  4. If criteria in step 2 are met and step 3 is negative, consider steroid therapy
  5. Use recommended dosing regimen and monitor for adverse effects
  6. Discontinue if no improvement after 72 hours or if complications develop

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Corticosteroid Therapy in Respiratory Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.

American journal of respiratory and critical care medicine, 2010

Research

Corticosteroids in Community-Acquired Pneumonia: A Review of Current Literature.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.